Open Orphan Share Discussion Threads

[lazarus2010] 25/1/2021 12:00

Not sure if this has been posted...

3rd Feb, I received invite via AJBell

Evening timings
18.00
Introduction
Roland Spencer, Head of Corporate Development - Shares
18.05
Strix Group
Mark Bartlett, CEO - Strix Group (KETL)
18.30
Anexo Group
Nick Dashwood Brown, Head of Investor Relations - Anexo Group (ANX)
18.55
Open Orphan
Cathal Friel, Executive Chairman - Open Orphan (ORPH)
19.20
Destiny Pharma
Neil Clark, CEO - Destiny Pharma (DEST)
19.45
End of webinar

[bobsworth] 25/1/2021 11:55

Yes all very frustrating when you see sh@t stocks rising on zero revenue growth.

Just needs Cathel now to land a few wearable contracts & do the deal on Imutex and this will rapidly re-rate again. Announcement of a fully booked 3rd facility would help too.

Cannot be long now with a presentation due 3rd Feb (week wed).

GLA

[hotteruk6] 25/1/2021 11:08

Coiled spring

[lako42] 25/1/2021 10:46

After 8 pieces of news I would expect to be discussing higher highs.

[judijudi] 25/1/2021 10:10

Higher lows
🤷‍a94;️🤷‍♂ᥧ9;🤔

[hotteruk6] 25/1/2021 09:16

Steadily higher lows, similar to July-Oct

[m5] 25/1/2021 08:10

1gw24 Jan '21 - 17:40 - 10937 of 10938

Morning all. Good post. Our time is coming.

[extrader] 24/1/2021 18:45

Hi 1gw,

Thanks for this !

The American marketing folk say that 'you sell the sizzle, not the sausage'....we appear to be in the fortunate position of having lots of both ;->

ATB

[1gw] 24/1/2021 17:40

But there's no reason Orph shouldn't make a big splash when (if) they announce their equivalent of ConserV. They have Covid-fighting potential in all 3 elements:

o Imutex - "Flu-v could be repurposed as a universal Covid vaccine"
o PrEPBiopharm - "has a viral prophylactic with expected utility against Covid-19"
o Immune modulator - "Team investigating potential Covid-19 applications"

So when CF is ready to announce his vehicle for monetising Imutex, PrEP & the immune modulator, he has scope to play up the Covid-19 fighting credentials, offering would-be investors a portfolio of 3 potential vaccines/therapies, alongside the more mature assets such as FLU-v and AGS-v.

[mark10101] 24/1/2021 17:06

1gw, thanks for the clarification, needed to look a bit more carefully! I have edited above.

[1gw] 24/1/2021 16:45

mark - FLU-v and AGS-v are sub-licensed to Imutex, not the other vaccines.

[stevesham] 24/1/2021 15:51

Thanks davidosh looking forward to attending your Mello event, and unless I am mistaken you never did say they were presenting, just being discussed which is good as you do have experts far more experienced than me, so I may just learn something both on the bull and bear side, but clearly hoping more bull than bear as Open Orphan is one of my larger holdings

[gregb] 24/1/2021 14:15

One minute the Company is presenting, next minute just being talked about. Make you mind up :-)

[davidosh] 24/1/2021 14:04

Open Orphan have presented twice before at our Mello events but we now provide Monday evening webinars every fortnight and the company are welcome to do a presentation at one. In the meantime...

Just to let shareholders and prospective investors know that we will be featuring Open Orphan at the #MelloMonday show tomorrow evening in the MelloBASH (Buy, Avoid, Sell or Hold)session with four leading analysts and investors assessing the current investment case for each of the four companies to be covered. The panel this week will also be looking at Kape Technologies, Ultimate Products Group and Twitter from a list of companies nominated.

We also have guest speaker Lord John Lee who writes regularly in the FT and has a session looking at takeovers and how investors miss out. Additionally there are three companies doing presentations so a chance to see HeiQ who only listed three months ago and Tatton Asset Management plus a Game changer company that will be revealed on the night. Lots more sessions too and with 600 in the audience it will make for a great show with lots of Q&A and audience polls including one about Open Orphan so do not miss it.



Tickets are still available and if you would like one at half price then enter the code MMTADVFN50

[backwoodsman] 24/1/2021 12:20

Not half as unethical as playing with viruses collected from bats and creating mutations that infect humans.

[mark10101] 24/1/2021 10:28

“However, there continues to be ethical and moral debates in the medical community over intentionally infecting healthy people, which is why the trial was only approved by the ethical committee and regulatory body after several months.”

[bobsworth] 24/1/2021 06:12

Open Orphan starts trials on nasal spray Covid-19 vaccines

Trials have begun on next-generation vaccine, says Cathal Friel, executive chairman of Irish pharma digital services firm

Daniel Murray - avatar
Daniel Murray
Business Reporter
@danieltmurray
24th January, 2021

[jeanesy] 23/1/2021 17:35

We can't be far away from those big announcements we are expecting now. In CF we trust. This is a company going places in the right space at the right time !!

[gregb] 23/1/2021 07:35

" Nothing wrong with alerting shareholders if their company is presenting"Orph investor relations have confirmed that they are NOT presenting at your event!

[elrico] 22/1/2021 18:39

It has been a good week for SBTX, even OPTI is showing signs of life, as is SNG, all of which include a Year to date chart. ORPH should be the next mover post result next week. SNG primed for FDA, UK or EU news that could come within weeks; then we can kiss current level goodbye and reel in £10 plus. 😎 DDDD need investors are waiting for NASDAQ just as OPTI investors are. There are other primers for both, of course.

[1gw] 22/1/2021 18:20

Could be ConserV and Orph bidding the price up for a ready-made Nasdaq vehicle...